Research Collaborations Clause Samples

A Research Collaborations clause defines the terms and conditions under which two or more parties agree to work together on research projects. It typically outlines the scope of the collaboration, the roles and responsibilities of each party, how intellectual property and research results will be handled, and any confidentiality requirements. For example, it may specify how data is shared, who owns inventions arising from the collaboration, and how costs are allocated. The core function of this clause is to establish clear expectations and protect the interests of all parties involved, thereby minimizing disputes and facilitating effective joint research efforts.
Research Collaborations. 4.2.1 Both Institutions will encourage research collaborations in areas of mutual interest. Details shall be specified in the particular formal written agreement for each collaboration. 4.2.2 Both Institutions will promote and facilitate exchange programs for postdoctoral fellow research. Such collaborative effort should be based on the mutual interests of the involved Principal Investigators in both Institutions and the prospective trainees. 4.2.3 In the event a joint research project is proposed by either Institution, such research efforts will be carefully scrutinized by both Parties to evaluate the value for the proposed joint effort, the qualifications of the proposed participating faculty members, and the location of the research activity. If a decision is made by both Parties to approve the proposed project as a possible joint effort, both Institutions will actively seek outside funding for the proposed joint research project. Final approval of the project will be subject, in part, to securing funding deemed sufficient by each Institution. 4.2.4 In such joint projects between the two Institutions, care will be taken to assure that there will be parity in the numbers and institutional ranks of the personnel involved. Any resulting publications shall include an acknowledgement of the contributions of each Institution in accordance with customary scientific practices. 4.2.5 The Institutions agree to comply with all applicable laws, including but not limited to the U.S. Export Administrative Regulations, that pertain to necessary licenses, certification standards, and legal considerations with regard to exports and export control. Research related international travel will be in compliance with the travel policies of both Institutions.
View SourceView Similar (2)
Research Collaborations. In the event that the Management Committee or its designee determines that any research task exceeds the scope or capacity available under the Scientific Research Services Agreement, the Joint Venture may contract separately with BECTON, QIAGEN or a Third Party (including any academic laboratory) to perform such research task. Such research contracts shall be on terms approved by the Management Committee or its designee.
View Source
Research Collaborations. Each of FOUNDATION or SRI, as the case may be, may sublicense the performance of its rights under the license for Ligand Patented Technology granted under Section 5.01 in bona fide research collaborations between either or both of them and not-for-profit entities ("Research Collaborators") which entities shall perform the sublicensed activities subject to the following conditions: (a) The FOUNDATION or SRI, and their respective Research Collaborators, as the case may be, may not assign or otherwise convey prospectively or after the fact any rights, or permit its employees, consultants or agents to convey any rights in the Option Technology except in the circumstance where LIGAND has failed to exercise its option rights under Section 6.01; (b) A Research Collaborator will be advised of LIGAND's rights under this Agreement and acknowledge them to LIGAND in writing; (c) FOUNDATION or SRI, as the case may be, will use its reasonable best efforts to assure that its employees, consultants, agents, and its Research Collaborator(s) use the Ligand Patented Technology solely in the course and scope of activities licensed under Section 5.01; and (d) In any collaboration initiated within five (5) years of the effective date of this Agreement between FOUNDATION or SRI, as the case may be, and FOUNDATIONS's former employee, ▇▇▇▇▇▇ ▇▇▇▇▇, Ph.D., or with his employer, in which he is an investigator and under which the right to sublicense is exercised by FOUNDATION or SRI, as the case may be, provision must be made for LIGAND to secure the same rights to inventions, discoveries and developments made by ▇▇. ▇▇▇▇▇ or persons under his direction as would be the case if ▇▇. ▇▇▇▇▇ were a FOUNDATION employee. FOUNDATION and/or SRI shall not permit, and they shall take reasonable steps, including bringing suit, to prevent any use of Ligand Patented Technology by a Research Collaborator of FOUNDATION and/or SRI in connection with their collaboration in violation of these conditions and outside the scope of the sublicenses permitted under this Section 5.02, and any breach by FOUNDATION and/or SRI of the foregoing shall constitute a material breach of this Agreement by that Research Collaborator's sublicensor, FOUNDATION or SRI, as the case may be. A Research Collaborator shall not have the right to grant any further sublicense of its rights obtained under this Section 5.02.
View Source
Research Collaborations. In the event that the Management Committee or its designee determines that any research task exceeds the scope or capacity available under the Scientific Research Services Agreement, the Joint Venture may contract with HMRI, ARIAD or a third party (including any academic laboratory) to perform such research. Such research contracts shall be on terms approved by the Management Committee or its designee; provided, however, that if the party performing the research is HMRI or ARIAD or an Affiliate of either, such agreement shall provide that any Technology developed in such research shall become the property of the Joint Venture.
View Source
Research Collaborations. 4.3.1 Both Institutions will encourage biomedical research collaborations in areas of mutual interest. While it is expected that such collaboration would include research in regenerative medicine, such as stem cell research, collaborations in other areas are also encouraged. Details shall be specified in the particular written agreement for each collaboration. 4.3.2 Both Institutions will promote and facilitate exchange programs for postdoctoral fellow training in biomedical research. Such collaborative effort should be based on the mutual interests of the involved Principal Investigators in both Institutions and the prospective trainees. 4.3.3 In the event a joint research project is proposed by either Institution, such research efforts will be carefully scrutinized by both Parties to evaluate the value for the proposed joint effort, the qualifications of the proposed participating faculty members, and the location of the research activity. If a decision is made by both Parties to approve the proposed project as a possible joint effort, both Institutions will actively seek outside funding for the proposed joint research project. Final approval of the project will be subject, in part, to securing funding deemed sufficient by each Institution. 4.3.4 In such joint projects between the two Institutions, care will be taken to assure that there will be parity in the numbers and institutional ranks of the personnel involved. Any resulting publications shall include an acknowledgement of the contributions of each Institution in accordance with customary scientific practices. 4.3.5 The Institutions agree to comply with all applicable laws, including but not limited to the U.S. Export Administrative Regulations, that pertain to necessary licenses, certification standards, and legal considerations with regard to exports.
View Source

Related to Research Collaborations

  • Research Collaboration Upon FibroGen’s request, the Parties will discuss conducting a research program funded by AstraZeneca and directed toward franchise enhancement and lifecycle management for HIF Compounds or other topics that the Parties determine relevant to the Products and the Field. Upon agreement on the terms of such research program, the Parties will enter into a separate agreement or amend this Agreement accordingly.

  • Research Program The term “

  • Collaboration 31.1 If the Buyer has specified in the Order Form that it requires the Supplier to enter into a Collaboration Agreement, the Supplier must give the Buyer an executed Collaboration Agreement before the Start date. 31.2 In addition to any obligations under the Collaboration Agreement, the Supplier must: 31.2.1 work proactively and in good faith with each of the Buyer’s contractors 31.2.2 co-operate and share information with the Buyer’s contractors to enable the efficient operation of the Buyer’s ICT services and G-Cloud Services

  • Collaboration activities 4.1 The Collaboration Suppliers will perform the Collaboration Activities and all other obligations of this Agreement in accordance with the Detailed Collaboration Plan. 4.2 The Collaboration Suppliers will provide all additional cooperation and assistance as is reasonably required by the Buyer to ensure the continuous delivery of the services under the Call-Off Contract. 4.3 The Collaboration Suppliers will ensure that their respective subcontractors provide all cooperation and assistance as set out in the Detailed Collaboration Plan.

  • Research Plan The Parties recognize that the Research Plan describes the collaborative research and development activities they will undertake and that interim research goals set forth in the Research Plan are good faith guidelines. Should events occur that require modification of these goals, then by mutual agreement the Parties can modify them through an amendment, according to Paragraph 13.6.